Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study
Author:
Funder
Ensign Endowment for Gynecologic Cancer Research
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00404-019-05104-0.pdf
Reference30 articles.
1. Matsuo K, Lin YG, Roman LD et al (2010) Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs 19:1339–1354
2. Mei L, Chen H, Wei DM et al. Maintenance chemotherapy for ovarian cancer. Cochrane Database Syst Rev. 2013:Cd007414
3. DiSilvestro PA, Fisher M, Pearl ML et al (2007) Pilot phase 2 trial of 4 months of maintenance pegylated liposomal Doxorubicin in patients with advanced ovarian cancer after complete response to platinum and Paclitaxel-based chemotherapy. Gynecol Obstet Invest 63:1–6
4. Ledermann JA, Hackshaw A, Kaye S et al (2011) Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer. J Clin Oncol 29:3798–3804
5. Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473–2483
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy;Journal of Clinical Medicine;2024-01-18
2. Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer;Molecular Pharmaceutics;2021-08-27
3. Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review;Journal of Drug Delivery Science and Technology;2021-02
4. Drug Delivery Approaches for Doxorubicin in the Management of Cancers;Current Cancer Therapy Reviews;2020-11-20
5. Chemotherapy induced immunogenic cell death alters response to exogenous activation of STING pathway and PD-L1 immune checkpoint blockade in a syngeneic murine model of ovarian cancer;2019-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3